Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis.
暂无分享,去创建一个
C. Masciocchi | V. Tombolini | F. Vittorini | G. Gravina | E. Limoncin | G. Grimaldi | R. Gimenez De Lorenzo | F. Marampon | C. Sorce | A. Chalaszczyk | L. Ferella | P. Franzese | M. Di Staso | Valeria Ruggieri | E. Varrassi | A. Chalaszczyk